StockNews.AISignal intelligencePublic signal · 1-minute delayed
Source-backed market context you can read and share without an account.
The rating upgrade and implied target upside support a bullish view, though this remains an analyst opinion rather than a confirmed catalyst.
What happened, with direct paths to the underlying reporting
Oppenheimer upgraded INCY to Outperform with a $144 target versus the posted price of $116.80, implying roughly 23% upside to the target.
Target: $144
Posted price: $116.8
Analyst firm: Oppenheimer
Analyst: Jay Olson
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.